Sign in:
 Email
 Password  save:
  
 Company Reports 
 
 
Membership is free, please Sign Up.
  
My Recent Searches
  Help
  
   
 
 
 
  
   
Insider Information:   Fuchs Henry J
Relationship:  
City:   Palo Alto
State:   CA
   
Insider Summary:
  
   
Companies Owned :   5    
Direct Shares   222,228    

Indirect Shares

   0      
Direct Value   $18,063,061    

Indirect Value

   $0      
Total Shares   222,228      
Total Value   $18,063,061      


Onyx Pharmaceuticals Inc $0 Biomarin Pharmaceutical Inc $17,448,765 Mirati Therapeutics, Inc. $614,296 Onyx Pharmaceuticals Inc $0 Biomarin Pharmaceutical Inc $17,448,765 Mirati Therapeutics, Inc. $614,296
 


Historical Performance :
Based on 6 Month Return Percentages
Buys 
Sells 

     Total Filings :
    0   
    0    

     Stock price went up :
    0   
    0    
     Stock price went down :
    0   
    0    
   
     Gain/Loss Ratio :
   0.0   
   0.0   
     Percentage Gain/Loss :
     0.0%
   0.0%
     
   
Holdings :
     Menu Company Name Ticker Relation Direct Date Direct Shares Indirect Date Indirect Shares Total Value Sold  
            Onyx Pharmaceuticals Inc ONXX EVP & Chief Medical Of... 2008-11-18 14,891 2006-05-15 0    Premium*  
            Ardea Biosciences Inc RDEA Director 2012-06-19 0 2007-12-05 0    Premium*  
            Biomarin Pharmaceutical Inc BMRN President, Worldwide R&D 2024-03-15 196,872 2009-03-02 0    Premium*  
            Genomic Health Inc GHDX Director 2019-11-08 0 2014-04-01 0    Premium*  
            Mirati Therapeutics, Inc. MRTX 2023-01-20 10,465 2020-01-03 0    Premium*  
* Premium Members only  

Records found :    294         Free Registration Required For Full Results.    Limit: 25

 Download
  Page 9 of 12
Ticker Company Name Relation   Off-Dir-10% Trans. Date Form Action Price Mkt Value D/I Shares    Holdings   
Rank

  
3m +/-  
Form
BMRN Biomarin Pharmaceutical I... EVP, Chief Medical Officer   •       –      –    2015-05-11 4 AS $121.64 $348,988 D/D (2,869) 83,646 0 -
BMRN Biomarin Pharmaceutical I... EVP, Chief Medical Officer   •       –      –    2015-05-08 4 D $121.66 $380,917 D/D (3,131) 86,515 0 -
BMRN Biomarin Pharmaceutical I... EVP, Chief Medical Officer   •       –      –    2014-08-05 4 OE $21.51 $215,100 D/D 10,000 86,550 0 -
BMRN Biomarin Pharmaceutical I... EVP, Chief Medical Officer   •       –      –    2015-03-16 4 AS $123.57 $5,105,166 D/D (41,315) 88,635 0 -
BMRN Biomarin Pharmaceutical I... EVP, Chief Medical Officer   •       –      –    2015-05-01 4 S $114.59 $47,442 D/D (414) 89,646 0 -
BMRN Biomarin Pharmaceutical I... EVP, Chief Medical Officer   •       –      –    2015-03-03 4 A $0.00 $0 D/D 13,400 89,950 0 -
BMRN Biomarin Pharmaceutical I... EVP, Chief Medical Officer   •       –      –    2015-04-30 4 A $51.26 $73,050 D/D 1,425 90,060 0 -
BMRN Biomarin Pharmaceutical I... EVP, Chief Medical Officer   •       –      –    2014-11-10 4 OE $21.51 $430,200 D/D 20,000 96,550 0 -
BMRN Biomarin Pharmaceutical I... EVP, Chief Medical Officer   •       –      –    2016-03-03 4 D $89.57 $272,562 D/D (3,043) 100,876 0 -
BMRN Biomarin Pharmaceutical I... President, Worldwide R&D   •       –      –    2020-04-24 4 AS $95.34 $1,917,617 D/D (20,000) 102,656 0 -
BMRN Biomarin Pharmaceutical I... President, Worldwide R&D   •       –      –    2020-04-30 4 A $62.59 $21,217 D/D 339 102,995 0 -
BMRN Biomarin Pharmaceutical I... President, Worldwide R&D   •       –      –    2020-07-13 4 AS $130.00 $2,991,430 D/D (23,011) 102,995 0 -
BMRN Biomarin Pharmaceutical I... President, Worldwide R&D   •       –      –    2020-07-20 4 AS $130.00 $16,430,570 D/D (126,389) 102,995 0 -
BMRN Biomarin Pharmaceutical I... EVP, Chief Medical Officer   •       –      –    2016-02-29 4 D $81.87 $4,622,708 D/D (56,464) 103,919 0 -
BMRN Biomarin Pharmaceutical I... President, Worldwide R&D   •       –      –    2021-03-22 4 D $78.52 $192,688 D/D (2,454) 106,142 0 -
BMRN Biomarin Pharmaceutical I... President, Worldwide R&D   •       –      –    2021-03-16 4 D $77.21 $174,417 D/D (2,259) 108,596 0 -
BMRN Biomarin Pharmaceutical I... President, Worldwide R&D   •       –      –    2021-03-15 4 D $78.39 $584,789 D/D (7,460) 110,855 0 -
BMRN Biomarin Pharmaceutical I... EVP, Chief Medical Officer   •       –      –    2016-06-03 4 D $90.00 $183,240 D/D (2,036) 113,878 0 -
BMRN Biomarin Pharmaceutical I... EVP, Chief Medical Officer   •       –      –    2016-08-26 4 AS $95.06 $1,425,924 D/D (15,000) 113,878 0 -
BMRN Biomarin Pharmaceutical I... President, Worldwide R&D   •       –      –    2016-11-25 4 AS $87.40 $1,310,988 D/D (15,000) 113,878 0 -
BMRN Biomarin Pharmaceutical I... EVP, Chief Medical Officer   •       –      –    2016-05-13 4 D $82.71 $168,398 D/D (2,036) 115,914 0 -
BMRN Biomarin Pharmaceutical I... EVP, Chief Medical Officer   •       –      –    2016-05-26 4 S $87.34 $1,317,100 D/D (15,000) 115,914 0 -
BMRN Biomarin Pharmaceutical I... EVP, Chief Medical Officer   •       –      –    2016-05-06 4 D $80.80 $252,985 D/D (3,131) 117,950 0 -
BMRN Biomarin Pharmaceutical I... President, Worldwide R&D   •       –      –    2021-03-15 4 A $0.00 $0 D/D 15,320 118,315 0 -
BMRN Biomarin Pharmaceutical I... President, Worldwide R&D   •       –      –    2022-03-08 4 A $0.00 $0 D/D 12,840 119,323 0 -
  294  Records found
  1   2   3   4   5   6   7   8   9  10   11   12      
  Page 9 of 12  
 
Free Registration Required For Full Results.    Limit: 25

 
 
  Transaction Code Key: Ownership Code Key
  B - Buy AB - Automatic Buy D - Direct Ownership
  S - Sell AS - Automatic Sell I - Indirect Ownership
OE - Options Exercised A - Aquired
  IO - Initital Ownership D - Disposed
 
 
    Copyright © 2024 j3sg.com | Disclaimer & Terms of use          Products & Service  About Us  Contact Us